Full Text
HPR250 Reimbursement Decisions for Innovative Drug Technologies in Poland: Duration of Reimbursement Processes and Impact of HTA Recommendation

Abstract

Authors

S Wierzganowska S. Malysiak-Szpond A Lipinska K Zmuda

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×